Literature DB >> 9826901

Prenatal diagnosis of congenital toxoplasmosis transmitted by an immunocompetent woman infected before conception. Reims Toxoplasmosis Group.

I Villena1, C Chemla, C Quereux, D Dupouy, B Leroux, F Foudrinier, J M Pinon.   

Abstract

We report a rare case of congenital toxoplasmosis transmitted by an immunocompetent woman infected before conception. Active toxoplasmosis was suspected due to persistent lymphadenitis with specific IgM, IgA, IgE antibodies. Prenatal diagnosis based on amniocentesis and fetal blood sampling at 24 weeks' amenorrhoea was positive on amniotic fluid, and fetal infection was confirmed after termination. In our opinion such cases need the same monitoring as when seroconversion occurs during the first trimester. A pregnancy-free interval of six to nine months is recommended after proven patent toxoplasmosis seroconversion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826901

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Preconception seroconversion and maternal seronegativity at delivery do not rule out the risk of congenital toxoplasmosis.

Authors:  C Chemla; I Villena; D Aubert; P Hornoy; D Dupouy; B Leroux; J P Bory; J M Pinon
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Clinical value of specific immunoglobulin E detection by enzyme-linked immunosorbent assay in cases of acquired and congenital toxoplasmosis.

Authors:  F Foudrinier; I Villena; R Jaussaud; D Aubert; C Chemla; F Martinot; J M Pinon
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Detection of specific immunoglobulin E during maternal, fetal, and congenital toxoplasmosis.

Authors:  I Villena; D Aubert; V Brodard; C Quereux; B Leroux; D Dupouy; G Remy; F Foudrinier; C Chemla; J E Gomez-Marin; J M Pinon
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

4.  Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women.

Authors:  Pierre Flori; Laetitia Tardy; Hugues Patural; Bahrie Bellete; Marie-Noëlle Varlet; Jamal Hafid; Hélène Raberin; Roger Tran Manh Sung
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

Review 5.  Development of Toxoplasma gondii vaccine: A global challenge.

Authors:  Ramesh Verma; Pardeep Khanna
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

6.  Association of gestational diabetes mellitus and negative modulation of the specific humoral and cellular immune response against Toxoplasma gondii.

Authors:  Ana Carolina de Morais Oliveira-Scussel; Paula Tatiana Mutão Ferreira; Renata de Souza Resende; Cristhianne Molinero Ratkevicius-Andrade; Angelica de Oliveira Gomes; Marina Carvalho Paschoini; Fernanda Bernadelli De Vito; Thaís Soares Farnesi-de-Assunção; Marcos Vinícius da Silva; José Roberto Mineo; Denise Bertulucci Rocha Rodrigues; Virmondes Rodrigues
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

7.  Prenatal and Early Postnatal Diagnosis of Congenital Toxoplasmosis in a Setting With No Systematic Screening in Pregnancy.

Authors:  Tijana Stajner; Branko Bobic; Ivana Klun; Aleksandra Nikolic; Jelena Srbljanovic; Aleksandra Uzelac; Irena Rajnpreht; Olgica Djurkovic-Djakovic
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 8.  Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings.

Authors:  Branko Bobić; Isabelle Villena; Eileen Stillwaggon
Journal:  Food Waterborne Parasitol       Date:  2019-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.